歌礼制药-B（01672）于2026年11月6日发布翌日披露报表，披露当日回购股份事宜。公告显示，公司已在香港联交所场内回购10.00万股普通股，占公司已发行股本约0.0095%，每股回购价介乎4.52港元至4.725港元，合计耗资约45.97万港元。
本次回购完成后，公司已发行股份数目维持1,052,202,859股，库藏股数量保持5,784,210股。根据公告，公司回购授权于2026年6月29日获股东大会通过，可回购股份数量为106,137,084股。截至本次回购，公司共计回购5,795,000股，占授权通过当日已发行股本约0.546%。
公司确认本次回购已遵守香港联合交易所有限公司证券上市规则的相关规定，且无重大变动。公告由公司秘书钟明辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.